In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Says 'Spray Hello' To Beco With UK Brand Revitalization Campaign

Executive Summary

Perrigo relaunches OTC nasal sprays under single 'Beco' brand supported by £1.7m multimedia marketing campaign.

You may also be interested in...



Ouch! Two UK Analgesic Ad Complaints: Reckitt Rapped, Perrigo Pardoned

Two UK advertising complaint verdicts delivered by the MHRA, Reckitt Benckiser's Nurofen Express (upheld) and Perrigo's Solpadeine Max (not upheld).

Perrigo Lights Smoking Cessation For Growth With Turnaround Woes 'Fixable'

As "market leader" in OTC nicotine replacement treatments, Perrigo should "be the one that's doing a lot of innovation," says CEO Murray Kessler. He discussed Perrigo's problems and potential sales drivers as it reported 2018 net sales of $4.7bn, down 4% , and Q4 net sales of $1.2bn, down 7%. Global consumer health product sales for year were flat at $3.9bn and Q4 sales were down 4% at $973m.

Perrigo Helping Pharmacists Get Over Misconceptions About Sleep Aids With UK Nytol Campaign

Perrigo has launched a UK pharmacy-facing trade campaign for Nytol to help pharmacists and pharmacy-staff get over their misconceptions about sleep aids and have better conversations with consumers about their sleep problems.

Topics

Related Companies

UsernamePublicRestriction

Register

LL1132087

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel